New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
09:44 EDTCRLCharles River Labs sees FY13 net sales growth 3%-5% ex-Vital River
Including Vital River, sees net sales growth 4%-6% in constant currency. Sees FY13 free cash flow $165M-$175M, CapEx $50M.
News For CRL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
06:33 EDTCRLCharles River Labs upgraded to Buy from Neutral at SunTrust
SunTrust upgraded Charles River Labs to Buy and raised estimates to reflect DSA segment revenue growth, an early stage industry recovery that creates long-term performance potential, and views valuation as attractive. Price target is $70.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use